%0 Journal Article
%T Endoscopic injection of lauromacrogol foam sclerotherapy for rectal cavernous hemangioma: A case report.
%A Chen L
%A Chen F
%A Jiang T
%A Deng Y
%A Shi G
%J Medicine (Baltimore)
%V 103
%N 28
%D 2024 Jul 12
%M 38996140
%F 1.817
%R 10.1097/MD.0000000000038919
%X <B>BACKGROUND: </B>Rectal cavernous hemangioma is a rare, benign vascular disease that seldom causes lower gastrointestinal bleeding, characterized by a high rate of misdiagnosis and missed diagnoses. Surgical treatment is considered to be relatively effective; however, it is accompanied by certain employed in the treatment of superficial hemangioma, boasting the advantages of minimally invasive surgery, including safety, effectiveness, reduced trauma, and rapid recovery. However, there is a lack of literature regarding the application of foam sclerosing agents for gastrointestinal hemangiomas.<BR><B>UNASSIGNED: </B>We present a case of a 60-year-old male who was admitted to our hospital with a history of recurrent hematochezia for >1 year and worsening symptoms for 1 week. The patient's medical history was unremarkable.<BR><B>METHODS: </B>Following colonoscopy, nuclear magnetic resonance imaging, computed tomography, and other examinations, the final diagnosis was rectal cavernous hemangioma.<BR><B>METHODS: </B>Due to the patient's refusal of surgery, endoscopic foam sclerotherapy using a lauromacrogol injection was performed after obtaining informed consent from the patient and their relatives.<BR><B>RESULTS: </B>Post-sclerotherapy, hematochezia symptoms ceased, and no adverse reactions were observed. Two months later, colonoscopy and nuclear magnetic resonance imaging showed that the hemangioma had almost completely disappeared, with only a small amount of tumor remnants, yielding a satisfactory curative effect.<BR><B>CONCLUSIONS: </B>Our findings indicate that endoscopic injection of a lauromacrogol foam sclerosing agent is a safe, effective, and minimally invasive treatment option for gastrointestinal cavernous hemangiomas.